Retraction Note: Isovitexin reduces carcinogenicity and stemness in hepatic carcinoma stem-like cells by modulating MnSOD and FoxM1

Affiliations

Xiaocheng Cao: Department of Pharmaceutical Science, Medical College, Hunan Normal University
Lihua Liu: Pharmacy Department, The Second Clinical Medical School of Jinan University, Shenzhen People’s Hospital
Qing Yuan: Department of Preclinical Medicine, Medical College, Hunan Normal University
Xiang Li: Department of Preclinical Medicine, Medical College, Hunan Normal University
Yinghong Cui: Department of Pharmaceutical Science, Medical College, Hunan Normal University
Kaiqun Ren: Department of Pharmaceutical Science, Medical College, Hunan Normal University
Chang Zou: Shenzhen Public Service Platform on Tumor Precision Medicine and Molecular Diagnosis, Shenzhen People’s Hospital
A. Chen: Department of Pharmaceutical Science, Medical College, Hunan Normal University
Chang Xu: Department of Pharmaceutical Science, Medical College, Hunan Normal University
Yebei Qiu: Department of Pharmaceutical Science, Medical College, Hunan Normal University
Meifang Quan: Department of Pharmaceutical Science, Medical College, Hunan Normal University
Jiansong Zhang: Department of Preclinical Medicine, Medical College, Hunan Normal University
Jianguo Cao: Department of Pharmaceutical Science, Medical College, Hunan Normal University
Xiangding Chen: Laboratory of Molecular and Statistical Genetics, College of Life Sciences, Hunan Normal University

Abstract

This article has been retracted. Please see the Retraction Notice for more detail: https://doi.org/10.1186/s13046-019-1244-6..

ISSN: 1756-9966 (Online)
Publisher: BMC
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://jeccr.biomedcentral.com/